Home › Funds › Cormorant Asset Management, LP › ATOS

Cormorant Asset Management, LP position in ATOS

ATOSSA THERAPEUTICS INC · Health Care

Cormorant Asset Management, LP reported holding 1,788,815 shares of ATOS (ATOSSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$30.7M, representing 2.19% of its reported portfolio and ranking #14 among its reported holdings. Cormorant Asset Management, LP first reported this position in Q3 2026.

Latest position (Q3 2026)1.79M sh
Reported value held$30.66M
Portfolio Weight2.19%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's ATOS position evolved

Cormorant Asset Management, LP first disclosed a stake in ATOS in Q3 2026 at 1,788,815 shares (US$30.7M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 1.79M $30.66M New

About ATOS and 13F data

ATOS (ATOSSA THERAPEUTICS INC) is a Health Care company. 62 other funds we track also report a position in ATOS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$120.8M), venBio Partners LLC (US$71.7M), Deep Track Capital, LP (US$55.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ATOS

All ATOS fund holders →

FAQ

How long has Cormorant Asset Management, LP held ATOS?

Cormorant Asset Management, LP has disclosed ATOS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Cormorant Asset Management, LP's current position in ATOS?

As of Q3 2026, Cormorant Asset Management, LP holds 1.79M shares of ATOS (ATOSSA THERAPEUTICS INC), valued at $30.66M, representing 2.19% of its reported portfolio and ranking #14.

Has Cormorant Asset Management, LP been buying or selling ATOS?

In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP newly opened its position in ATOS.

Which other funds hold ATOS?

Other major institutional holders of ATOS include Frazier Life Sciences Management, L.P., venBio Partners LLC, Deep Track Capital, LP, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.